id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-V-3796-0002,FDA,FDA-2026-V-3796,Acknowledgment Letter from FDA CDRH to Bernhard Blazier,Other,Acknowledgement Letter/Receipt,2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T20:05:28Z,,0,0,09000064b9258455
FDA-2026-V-3796-0001,FDA,FDA-2026-V-3796,Variance Application from Bernhard Blazier,Other,Application for Variance (VAR),2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T20:05:22Z,,0,0,09000064b9258451
FDA-2026-V-3796-0003,FDA,FDA-2026-V-3796,Variance Approval Letter to Bernhard Blazier,Other,Approval for Variance (VRA),2026-05-11T04:00:00Z,2026,5,2026-05-11T04:00:00Z,,2026-05-11T20:05:35Z,,0,0,09000064b92ca556